ANI Pharmaceuticals Projects Robust Growth for 2025 Amid Product Expansion

Baudette, Monday, 13 January 2025.
ANI Pharmaceuticals anticipates substantial revenue growth in 2025, driven by product expansion and strategic initiatives, with net revenues projected between $739 million and $759 million.